about
Multiwalled carbon nanotube hybrids as MRI contrast agentsAdvances in functional and structural imaging of the human lung using proton MRI.Intensified surveillance for early detection of breast cancer in high-risk patientsPrinciples of T2 *-weighted dynamic susceptibility contrast MRI technique in brain tumor imaging.Gadolinium deposition within the dentate nucleus and globus pallidus after repeated administrations of gadolinium-based contrast agents-current status.Normal saline as a natural intravascular contrast agent for dynamic perfusion-weighted MRI of the brain: Proof of concept at 1.5T.Lanthanide(III) complexes of rhodamine-DO3A conjugates as agents for dual-modal imagingMRI characterization of cobalt dichloride-N-acetyl cysteine (C4) contrast agent marker for prostate brachytherapyStable confinement of positron emission tomography and magnetic resonance agents within carbon nanotubes for bimodal imagingCompensatory biliary and urinary excretion of gadobenate ion after administration of gadobenate dimeglumine (MultiHance(®)) in cases of impaired hepatic or renal function: a mechanism that may aid in the prevention of nephrogenic systemic fibrosis?Gadolinium retention in the body: what we know and what we can do.DNA-gadolinium-gold nanoparticles for in vivo T1 MR imaging of transplanted human neural stem cells.Combining hyperpolarized 13 C MRI with a liver-specific gadolinium contrast agent for selective assessment of hepatocyte metabolism.An experimental phantom study of the effect of gadolinium-based MR contrast agents on PET attenuation coefficients and PET quantification in PET-MR imaging: application to cardiac studies.Diagnostic power of diffusion-weighted magnetic resonance imaging for the presence of lymph node metastasis: A meta-analysis.Adult stem cell lineage tracing and deep tissue imaging.Gadolinium-Based Contrast Agent Accumulation and Toxicity: An Update.Interpreting body MRI cases: what you need to know to get started.Magnetic Resonance Imaging of the Liver (Including Biliary Contrast Agents) Part 1: Technical Considerations and Contrast Materials.Gadolinium-based contrast agents: A comprehensive risk assessment.Gadolinium based contrast agents in current practice: Risks of accumulation and toxicity in patients with normal renal function.Analytical interference in serum iron determination reveals iron versus gadolinium transmetallation with linear gadolinium-based contrast agents.Fluorescent single-stranded DNA-based assay for detecting unchelated Gadolinium(III) ions in aqueous solution.An Aptamer-based Sensor for Unchelated Gadolinium(III).Are there differences between macrocyclic gadolinium contrast agents for brain tumor imaging? Results of a multicenter intraindividual crossover comparison of gadobutrol with gadoteridol (the TRUTH study).Quantitative Methods in Abdominal MRI: Perfusion Imaging.Reduced urothelial regeneration in rat bladders augmented with permeable porcine small intestinal submucosa assessed by magnetic resonance imaging.Central nervous system gadolinium accumulation in patients undergoing periodical contrast MRI screening for hereditary tumor syndromes.Absence of clinical cerebellar syndrome after serial injections of more than 20 doses of gadoterate, a macrocyclic GBCA: a monocenter retrospective study.Follow-up of pineal cysts in children: is it necessary?Distribution and chemical forms of gadolinium in the brain: a review.In vivo dentate nucleus MRI relaxometry correlates with previous administration of Gadolinium-based contrast agents.Gadolinium deposition in the brain: association with various GBCAs using a generalized additive model.Gadopentetate but not gadobutrol accumulates in the dentate nucleus of multiple sclerosis patients.Intravenous injection of gadobutrol in an epidemiological study group did not lead to a difference in relative signal intensities of certain brain structures after 5 years.Balancing the intermolecular forces in peptide amphiphiles for controlling self-assembly transitions.Hearing function after intratympanic application of gadolinium-based contrast agent: A long-term evaluation.Probing peptide amphiphile self-assembly in blood serum.Iron(III)-Tannic Molecular Nanoparticles Enhance Autophagy effect and T1 MRI Contrast in Liver Cell Lines.pH-responsive theranostic nanocomposites as synergistically enhancing positive and negative magnetic resonance imaging contrast agents.
P2860
Q26740054-3D2D69B8-9B2F-4482-9306-E2FF7A6920E8Q30366067-AEC4081A-F58D-4253-AD8A-60DB0C42F6B8Q30392157-9CA59D0D-EF87-44BD-B381-372CF1E59594Q30818733-A63B55E1-7197-46F8-A3D4-F2755ADECE9DQ31045014-64F1A872-1059-4AD7-87CC-41544B928EB7Q31086314-A633616F-A304-4D49-A3FB-16F07984FAC0Q33623967-22CD654F-C769-4FF0-B850-A07C54D5B1A9Q33878029-5CBC26E8-2F99-48D0-8762-6C012C9CD759Q34205213-CD5B1E7E-E736-432F-BD11-72D1239F2383Q36295407-9A905E1F-C18C-47BC-A80D-E0487B88992AQ36329191-864BA454-261B-43FF-AF5D-4FAB8A6D6817Q36385087-3BBC37F3-9C27-40C1-A7D5-5D9E836A35EDQ37503563-AA007518-9E25-4D17-8559-A1FADC007FDBQ37586019-13901EDE-1967-4CD3-B6F0-8266EAD684FFQ38635476-3C9E5B21-817D-42FB-AB6E-C4F840DFB50CQ38658521-4B389DF4-4C95-4258-968D-661F64F88FCFQ38667169-C5EEF375-1168-419C-9CA6-C8E75AE43C26Q38905110-608DDEA8-B898-4BE0-B06F-D533BB189236Q38981471-3192D3A4-6213-4352-82B8-D259BF15D82EQ39022872-D99A633F-3E09-40F5-9D38-BB8A78C21942Q41014009-2A47ED04-8B0C-47CF-9C50-71E6DC3A5F97Q42981019-6C03BF04-335E-46AF-A5FB-2D666742ECF4Q45975716-BC03F06F-B2C2-45A6-A103-A14F3C1D7AF8Q46276527-834F95A7-CCCE-4B81-B165-3D94AFB88B3AQ46805155-955A21BA-6CB8-4637-9B9B-D2A081865EF8Q47412444-DFADE2D0-29B5-4A3C-BF84-45011C072C2FQ47681067-C2A3E7C9-B186-40DD-A1E5-AB8E6E845470Q47875932-792AD00D-3986-4E59-9AF8-20B46A5ACE76Q47909842-E6667D26-784A-4A3F-9259-5DC48210FFF8Q48099425-DD9EC3F0-90D9-4B9F-8779-E7F7F92269E6Q48177361-24381A5D-8139-4A62-A073-FACEC19D035DQ48231937-1D26E5AE-E614-447D-B61C-9A365989FA6EQ48359444-565A9DCA-44E3-48F3-965A-76EDF9DAC294Q48493942-1D6B47F5-A796-4387-8D49-0FF7ECBAA614Q48715204-60DAC446-707F-461D-B88B-0C572A0FE84BQ48771490-4A75CE66-943A-4BF3-892F-F5B3C6673BCAQ50352780-E9E10FD0-146F-4D0E-8B09-30118B40F3F7Q52654631-7A70C2F7-8D72-4697-B1C3-D93E86D3EA36Q55007574-ED24A09A-92CC-4BB2-8AD4-ECB9D32199E6Q55339815-37B77571-FE55-4A22-9A04-7246B7D8E84F
P2860
description
2012 nî lūn-bûn
@nan
2012 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
MRI contrast agents: basic chemistry and safety.
@ast
MRI contrast agents: basic chemistry and safety.
@en
type
label
MRI contrast agents: basic chemistry and safety.
@ast
MRI contrast agents: basic chemistry and safety.
@en
prefLabel
MRI contrast agents: basic chemistry and safety.
@ast
MRI contrast agents: basic chemistry and safety.
@en
P2093
P2860
P356
P1476
MRI contrast agents: basic chemistry and safety.
@en
P2093
Dapeng Hao
Frank Goerner
Michael Tweedle
Val M Runge
P2860
P304
P356
10.1002/JMRI.23725
P577
2012-11-01T00:00:00Z